Downloadable Slidesets

Share

Program Content

Activities

  • Overview: BTK Inhibitors in CLL
    Overview of the BCR Pathway and Use of BTK Inhibitors in CLL
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • Selecting First-line Therapy in CLL
    Addressing the Medical Need in CLL: Selecting First-line Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • BTK Inhibition in R/R CLL
    BTK Inhibitors for Relapsed/Refractory Chronic Lymphocytic Leukemia
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • <i>EP</i>: BTK Inhibitors in CLL
    ExpressPoints: Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2020

    Expires: December 08, 2021

Faculty

cover img faculity

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

cover img faculity

Susan M. O Brien, MD

Professor of Medicine
Department of Leukemia
University of Texas M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

ProCE Banner

Supporters

AstraZeneca

BeiGene, Ltd.